Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call

Rhea-AI Summary

Charles River Laboratories International, Inc. (NYSE: CRL) will announce its Q4 2022 and full-year 2022 financial results along with guidance for 2023 on February 22, before market opening. A conference call is scheduled for 8:30 a.m. ET on the same day to discuss the results. Investors can access the live webcast through the Investor Relations section of the company's website. Charles River provides critical services and products to pharmaceutical, biotechnology companies, and academic institutions worldwide, aiming to enhance the research and development of new therapies.

Positive

• Upcoming financial results release may indicate strong performance.
• Provision of 2023 guidance could attract investor interest.

Negative

• None.

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2022 financial results and provide 2023 guidance on Wednesday, February 22^nd, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, February 22^nd, at 8:30 a.m. ET.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005079/en/

Investor Relations:

Todd Spencer

Corporate Vice President, Investor Relations

781.222.6455

todd.spencer@crl.com

Source: Charles River Laboratories International, Inc.

FAQ

When will Charles River Laboratories release its Q4 2022 financial results?

Charles River Laboratories will release its Q4 2022 financial results on February 22, 2023.

What time is the conference call scheduled for discussing the 2022 financial results?

The conference call is scheduled for 8:30 a.m. ET on February 22, 2023.

How can investors access the conference call?

Investors can access the conference call via a live webcast on the Investor Relations section of the Charles River website.

What is the stock symbol for Charles River Laboratories?

The stock symbol for Charles River Laboratories is CRL.

What type of services does Charles River provide?

Charles River provides essential products and services to accelerate research and drug development for pharmaceutical and biotechnology companies.